WHY BRITAIN'S THE SICK WOMAN OF EUROPE; We've Poured Billions into the NHS, Are Pioneers in Medical Research - but British Women Would Still Be Better off Being Ill in Iceland

Daily Mail (London), May 18, 2010 | Go to article overview

WHY BRITAIN'S THE SICK WOMAN OF EUROPE; We've Poured Billions into the NHS, Are Pioneers in Medical Research - but British Women Would Still Be Better off Being Ill in Iceland


Byline: ANGELA EPSTEIN

WOMEN are more likely to die early in Britain than in virtually every other western European country. It's an astonishing fact for a place which has always prided itself in the skill of its clinicians and world-leading research.

Yet over the past 40 years there has been an astounding downward spiral in female survival rates in the UK compared with other countries. According to the respected medical journal The Lancet, British women have fallen from 15th to 20th place in a league of death rates in 22 western European nations (the report investigated deaths from disease as well as fatalities in accidents and childbirth). Overall, fewer women are dying earlier, however, in the UK survival rates are not improving as fast as they are elsewhere.

How could this have come to pass -- especially when there has been a steady rise in the amount of money spent on health by Government? The fact is, while the amount spent here has risen from 6.8 per cent of our national income in 1997 to about 8.7 per cent in 2008, other countries such as France and Germany still spend more as a percentage.

Leading cancer specialist Professor Karol Sikora says: 'It's tragic and outrageous that the NHS has tripled its spending over the past decade and yet -- due to bloated and unnecessary administration and poor policy such as artificial targets -- we still perform so badly.'

A lack of resources is partly to blame for our poor results. An extensive study last year found that in Britain there are 8.2 MRI and CT scanners per million people; the European average is 11. There are also far fewer doctors in Britain: 2.5 per 1,000 population, compared to 3.4 in France, for instance. This causes delays in diagnosis.

Just as significant is NHS rationing of lifesaving drugs -- for example, the bowel cancer drug Avastin and Nexavar, the only treatment offering any chance of survival for patients with advanced liver cancer -- are routinely used in other European countries. These drugs typically offer three to six months of extra life, but some patients can survive for years. Although the drug-approving body NICE agrees they work, it says the health system cannot afford them.

Despite the much-heralded reduction in waiting times, these patients often wait longer between scanning, diagnosis and treatment than in other European countries. In France, for instance, the investigation for breast cancer -- the appointment, scan and diagnosis -- is all done within 48 hours, says Professor Sikora.

'Here we have a long, drawn-out appointment system where patients wait to see a doctor, then a specialist, then for the CT scan and then the results. It can all go on for months -- allowing time for cancer to spread and become more difficult to treat.

'The Government prides itself with the fact that suspected cancer patients can see a specialist within two weeks of their GP deciding they need a referral. It is the curse of the British public sector that everything involves waiting -- even though we have a good breast screening programme.'

THE good news is death rates for most cancers are falling; however, we still lag behind most of Europe. A damning league table, compiled by the highly respected Eurocare-4 study, ranked Britain 14th of 19 European countries in a survey of five-year survival rates for any cancer (that is survival for five years or more from diagnosis).

Expenditure is an issue -- 5 to 6 per cent of NHS expenditure goes on cancer, compared with 7 per cent in France and 9 per cent in Germany. Another issue is the need for better early diagnosis at GP level, say experts. This is partly a training issue, but it also reflects GPs' reluctance to refer because of costs.

The reason that small countries such as Iceland fare better than us, say experts, is that patients are in a progressive healthcare system, looked after by a greater number of doctors. …

The rest of this article is only available to active members of Questia

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

WHY BRITAIN'S THE SICK WOMAN OF EUROPE; We've Poured Billions into the NHS, Are Pioneers in Medical Research - but British Women Would Still Be Better off Being Ill in Iceland
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Help
Full screen

matching results for page

    Questia reader help

    How to highlight and cite specific passages

    1. Click or tap the first word you want to select.
    2. Click or tap the last word you want to select, and you’ll see everything in between get selected.
    3. You’ll then get a menu of options like creating a highlight or a citation from that passage of text.

    OK, got it!

    Cited passage

    Style
    Citations are available only to our active members.
    Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

    1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

    Cited passage

    Thanks for trying Questia!

    Please continue trying out our research tools, but please note, full functionality is available only to our active members.

    Your work will be lost once you leave this Web page.

    Buy instant access to save your work.

    Already a member? Log in now.

    Author Advanced search

    Oops!

    An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.